Background: Racial disparities persist in access to kidney transplantation. Racial differences in preemptive referral, or referral prior to dialysis start, may explain this discrepancy. 
| INTRODUC TI ON
Kidney transplantation is the optimal treatment for most of the >700 000 adults being treated for end-stage renal disease (ESRD) in the United States.
1-3 ESRD Network 6 (North Carolina, South Carolina, and Georgia) has the highest prevalence of ESRD in the United States 4 and the lowest kidney transplantation rates 5, 6 with African Americans being 59% less likely to receive a kidney transplant compared to white patients. 7 It has been shown that the sooner an ESRD patient receives a transplant, the better the patient's health outcomes following transplantation. 8, 9 Particularly, preemptive deceased donor or living donor transplantation, or receipt of a transplant prior to dialysis start, has been shown to improve graft function, as well as graft and patient survival. [10] [11] [12] [13] African Americans are less likely to be placed on the deceased donor waitlist, 14, 15 have longer time on dialysis before accessing the deceased donor waitlist, 16 and are less likely receive a preemptive kidney transplant 17, 18 compared to white patients; however, it is unknown whether the disparity is caused by delayed referral for transplant evaluation or something else. Research has shown that even after controlling for clinical factors and availability of living donors, the racial disparity in kidney transplantation, between African Americans and white patients, persists. 19, 20 Kasiske et al 14 hypothesized that the racial disparity in waitlisting could be attributed to poor predialysis care, although they did not have access to predialysis patient data to test this hypothesis.
Data on key steps early in the transplantation process, including when a patient is referred for transplant, 21 are not collected in national surveillance data. Several smaller, regional studies have found differing results with respect to racial differences in dialysis facility-level referral for kidney transplantation. Alexander et al 22 found that African
Americans in Indiana, Kentucky, and Ohio had a ~44% lower odds of transplant referral and completion of the transplant evaluation to achieve waitlisting. However, these distinct steps were not analyzed separately. More recently, we reported that, in Georgia, although
African American ESRD patients were surprisingly 20% more likely to be referred for kidney transplantation within 1 year of starting dialysis, these referred patients were 27% less likely to be waitlisted within 1 year, compared to white patients. 23 Similar to Kasiske et al, we hypothesized that this surprising finding could be due to a greater proportion of white patients being preemptively referred for transplant evaluation, compared to African Americans. Thus, the primary aim of this study was to describe whether there were racial disparities in preemptive referral for kidney transplantation evaluation in Georgia. In addition, we sought to investigate whether racial disparities in waitlisting and living donor transplantation persisted even among patients who were preemptively referred for kidney transplant evaluation.
| MATERIAL S AND ME THODS

| Data sources
Patient-level data on referrals for kidney transplant evaluation were collected from all three adult transplantation centers in Georgia were either African American (n = 5547) or white (n = 2205) were included in our analysis. Collection of Georgia referral data was retrospective, and our study was approved by institutional review boards at each of the three transplant centers.
| Study variables
| Race
Patient race was recorded by providers on the CMS-2728 form and is derived from the medical record. Race was dichotomized as African American or white. Patients with missing (n = 47) or other race/ethnicity were excluded due to small numbers (white Hispanic = 204; Other = 291).
| Outcome
The primary outcome examined was preemptive referral for kidney 
| Other patient-and facility-level characteristics
Patient characteristics included demographic and clinical data reported on the Medicare ESRD medical eligibility form (CMS-2728).
The CMS-2728 form is completed for every dialysis patient within 
| Statistical analysis
Descriptive statistics were calculated for patient-and neighborhoodlevel factors for the total referred population and stratified by race.
We also tested for significant difference between patient-and neighborhood-level factors and race using chi-square or KruskalWallis tests. Bivariable analysis was performed to determine the association between patient-and neighborhood-level characteristics, including race, and preemptive referral for transplant evaluation.
Crude and adjusted Cox proportional hazards models were used to determine the association between preemptive referral, and waitlisting and living donor transplantation. We used adjusted logistic regression to determine the association between African American vs white race and preemptive referral. Demographic and clinical characteristics were considered for potential inclusion in the model a priori if they had been previously described as a factor associated with the outcome of interest. To assess racial disparities in access to kidney transplantation among patients preemptively referred for transplant evaluation, we used Cox proportional hazards models for waitlisting and living donor transplantation. Adjusted Cox proportional hazards models were determined using a four-step process: also assessed death as a competing risk for our secondary outcomes.
| RE SULTS
| Study population
As previously described, 23 patients were preemptively referred for transplant evaluation. Among all patients referred, there was a significant difference between insurance status (χ 2 = 148.5; P < 0.001), and a higher percentage of white referred patients had diabetes (χ 2 = 30.1; P < 0.001) and cardiovascular disease (χ 2 = 68.5; P < 0.001) compared to African American patients (Table 1) 
| Preemptive referral and patient characteristics
The majority of the patients referred to a Georgia transplant center for transplant evaluation were African American (71.6%), although only 17.5% were preemptively referred and were significantly less likely to be preemptively referred (χ 2 = 98.2; P < 0.001) compared to white patients. 
| D ISCUSS I ON
In this study, after covariate adjustment, we found that 20% of pa- Our previous report on the variation of transplant referral among dialysis patients in Georgia showed African Americans were 1.22
times more likely to be referred within 1 year of starting dialysis. 23 This study supports our hypothesis that the increased likelihood of African Americans being referred for kidney transplant evaluation after starting dialysis may be at least partially due to a selection bias of the sample, where white patients are more likely to be referred for transplant evaluation before starting dialysis (preemptively referred). Our previous report also showed that although African
Americans were more likely to be referred for transplant within 1-year of starting dialysis, they were 23% less likely to be waitlisted within 1 year of referral. 23 Myaskovsky et al's 20 longitudinal study of
adults referred to the University of Pittsburgh Starzl Transplant
Institute and completed two rounds of interviews reported that when controlling for income, perceived discrimination, and transplant knowledge, race was no longer significantly associated with being eligible for a transplant, and patients with more transplant knowledge taking less time to be accepted for a kidney transplant. 20 Kasiske et al 14 investigated the variables associated with placement on the kidney transplant waitlist and found that African Americans were 53% less likely (OR = 0.47) to be preemptively waitlisted compared to white patients. Kasiske 14 hypothesized the racial disparity in preemptive listing was partially caused by the lack of adequate health care and predialysis care by a nephrologist. As identified by Kalantar-Zadeh et al, 26 there is an urgency to examine the transition of care from advanced CKD to renal replacement therapy, including kidney transplantation. They identified this "prelude" period and report major knowledge gaps that need to be addressed by primary care and nephrologists that include the best timing for, and optimal type of renal replacement therapy, which could vary across 
TA B L E 1 (Continued)
F I G U R E 1 Crude and adjusted* survival analysis determined the association between preemptive referral status and either placement on the deceased donor waiting list or receipt of a living donor kidney transplantation, overall and stratified by race (white and African American). *Survival analysis was used to obtain the crude and adjusted hazard ratios. Final, adjusted survival model includes sex, age, attributed cause of end-stage renal disease, body mass index, hypertension, diabetes, chronic obstructive pulmonary disease, tobacco, cancer, congestive heart failure, insurance type, and neighborhood poverty. Multiple imputation handled missing data within the adjusted model, for health insurance (0.17%), neighborhood-level poverty (2.78%), and body mass index (2.36%) demographics. The management of CKD and kidney failure requires a multidisciplinary, patient-centered approach and possible integration of a comprehensive scoring system 27 across specialties, which may help determine the best timing for renal replacement therapy and referral for kidney transplant evaluation. 26 A multidisciplinary approach could also improve patient education and provide patients more knowledge about treatment options, including transplant, and could significantly shorten their time to transplant. 20 Importantly, our results focusing only on the group of patients who were preemptively referred for transplant evaluation showed no significant difference in waitlisting between preemptively referred African Americans and white patients, supporting the hypothesis that when patients are referred to a nephrologist prior to dialysis, the racial disparity in waitlisting is mitigated. Given our findings that show early referral is associated with improved probability of placement on the deceased donor waiting list or receipt of living donor kidney transplantation, primary care physicians should regularly screen their high-risk patients for kidney failure and refer patients to a nephrologist to consider transplant options as early, in the course of disease, as possible. Public policy that improves or maintains health insurance coverage could assist high-risk adult patients to complete annual screenings and detect decreasing kidney function that could be monitored by either a primary care physician or nephrologist.
Literature shows that the longer a patient is on dialysis, the worse the post-transplant outcomes. 8, 11, 28, 29 With the national median time to transplant for newly listed candidates of 3.5 years, 4 timeliness of referral is important. Late referral may limit opportunities for patient education 30 about transplantation, particularly living donor transplant as a treatment option, as well as the option for preemptive transplantation, while increasing the risk of death on dialysis 4, 31 and the risk of graft failure or patient death after transplant.
11,28
While some literature shows that 6 months on dialysis may not be associated with poor outcomes, 29 single studies have reported that the average time from first referral to placement on the waiting list is longer than this. 7, 16 We report that preemptively referred patients were more likely to be placed on the deceased donor waiting list or receive a living donor kidney transplantation, compared to patients Our study interpretations are limited. Although our study is, to our knowledge, the largest regional study of preemptive kidney transplant referral to date, it is limited to Georgia and does not 
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